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Infection by Leishmania species is increasing worldwide. It was hypothesized recently that cats act as a secondary reservoir for
Leishmania infection. The aim of the present study was to assess the prevalence of Leishmania infantum antibodies and DNA in
blood samples collected in a sample of stray cats in metropolitan area of Milan in northern Italy, which is a nonendemic area for
leishmaniasis. An indirect immunofluorescence antibody test for L. infantum showed that 59 of 233 cats (25.3%) were seroreactive,
38 samples (16.3%) had antibody titers of 1 : 40, 15 (6.4%) had antibody titers of 1 : 80, and 6 (2.6%) had antibody titers of 1 : 160.
Feline immunodeficiency virus (FIV) seropositive status was statistically associated with seroreactivity to L. infantum (𝑃 = 0.01) as
shown by univariate andmultivariate logistic regression (𝑃 = 0.0098; OR= 7.34). All blood samples that were tested using real-time
PCRwere negative for parasite DNA.These results were surprising, since no autochthonous human or canine cases of leishmaniasis
have ever been reported in this region of northern Italy. It is possible that this high seroreactivity to L. infantum could be due to
cross-reactionwith antigens fromother parasites. Additional studies that include parasite isolation are needed to clarify our findings
on feline leishmaniasis in this region.
1. Introduction
Leishmaniasis in the Old World is caused by the protozoa
Leishmania infantum. It is prevalent in countries in the
Mediterranean basin, and dogs are the main reservoir of the
parasite in that region [1]. In recent years, autochthonous
cases of human and canine disease have been recorded at
higher latitudes, namely, in Germany [2, 3], The Netherlands
[4], and North America [5]. Infections have also been
reported in species other than dogs and humans, including
horses [6] and cows [7]. There have been numerous reports
of feline leishmaniasis (FeL), mostly in cats living in known
endemic areas [8–10]; some of the cats had concurrent
immunosuppressive infections [9–11]. In countries in south-
ern Europe, where canine leishmaniasis (CanL) is endemic,
serological investigations of feline populations have revealed
seroprevalence rates ranging from less than 1% to more than
60% [9–21]. Given the diffusion of Leishmania infection and
the lack of information regarding infection rates in cats in
the Milan metropolitan area in northern Italy, the aim of the
present study was to assess the prevalence of leishmaniasis
in a large representative sample of stray cats from this
nonendemic area. A secondary aim was to analyze the results
according to clinical, laboratory and infectious data.
2. Materials and Methods
2.1. Feline Population. During a 2-year period (January 2008
to January 2010), blood samples were collected from 233
European shorthair stray cats from urban colonies in Milan,
northern Italy, during a trap-neuter-release (TNR) program
that was approved by the local authority of the city council.
The program was conducted as described previously [22].
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2.2. Data Collection. The following data were recorded: sex
(𝑛 = 233), age (𝑛 = 233), body condition score (BCS)
(𝑛 = 215), area of colony of provenance, that is, one of
the seven municipalities of Milan (𝑛 = 233), health status
based on physical examination (𝑛 = 233), and dermatological
evaluation (𝑛 = 121). Cats were classified as healthy or
unhealthy depending on the clinical findings (Table 1).
2.3. Sample Collection. Whole blood samples were collected
by cephalic or jugular venipuncture into tubes with EDTA
anticoagulant for complete blood cell (CBC) count and
polymerase chain reaction (PCR) testing and into empty
tubes for serology. All samples used for serology and PCR
were stored at −20∘C until use.
2.4. Hematological and Serological Examination. Within 24
hours of sample collection, a CBC count was performed on
whole blood (𝑛 = 127) using an ADVIA 120 System (Siemens
Healthcare Diagnostics, Milan, Italy). Cats were categorized
as having alterations in the CBC as shown in Table 1.
Serological assessment was performed to determine the
presence of the following: antibodies to the feline immuno-
deficiency virus (FIV) relative to the gp40 and p24 FIV
antigens, the feline leukemia virus (FeLV) p27 antigen (Snap
FeLV/FIV Combo Plus Test, Idexx Laboratories, Hoofddorp,
The Netherlands) (𝑛 = 137), and Toxoplasma gondii IgG
antibodies (IFAT, Fuller Laboratories, Fullerton, CA, USA)
(𝑛 = 79). The results of these serological tests have been
already published [22] and were reanalyzed with the present
results.
For various technical reasons, not all data were available
for all 233 cats.
2.5. Indirect Immunofluorescence Antibody Test. The pres-
ence of anti-L. infantum antibodies was measured by an
indirect immunofluorescence antibody test (IFAT) per-
formed according to the recommendations of OIE [23]
using MHOM/IT/80/IPT1 as a whole-parasite antigen fixed
on multispot slides (Bio Merieux Spa, Florence, Italy)
and fluorescently-labeled antifeline gamma globulin (Sigma
Aldrich, Milan, Italy) as conjugate. Positive sera were diluted
serially and tested to establish the maximum reaction titer,
starting at a dilution of 1 : 40. Positive and negative controls
were included on each slide.
2.6. PCR. L. infantum DNA was amplified from 200𝜇L
of whole blood by real-time PCR using the Illustra Blood
genomicPrep Mini Spin kit (GE Healthcare, Milan, Italy)
following the manufacturer’s instructions. The target for
amplification was a 116-bp fragment in the constant region of
the kDNAminicircle of L. infantum. This is one of the kDNA
minicircle families that is used to identify the Leishmania
genus. The primers used were QLK2-UP 5󸀠-GGCGTTCTG-
CGAAAACCG-3󸀠 and QLK2-DOWN 5󸀠-AAAATGGCA-
TTTTCGGGCC-3󸀠; the TaqManprobes were Q Leish Probe
2 and 5󸀠-FAM TGGGTGCAGAAATCCCGTTCA-3󸀠-Black
Hole.
2.7. Statistical Analysis. Univariate analysis of the categorical
data was performed using the chi-square test or Fisher’s exact
test. Any parameters statistically linked to IFAT seroreactivity
for L. infantum or to the presence of L. infantum DNA as
detected by PCR were used in a logistic regression model to
test for independent risk factors associated with the L. infan-
tum positivity. Associations were considered statistically sig-
nificant when 𝑃 < 0.05; both the 𝑃 value and odds ratio (OR)
are reported. Data were analyzed using MedCalc Software
(version 12.3.0; Mariakerke, Belgium).
3. Results
The characteristics of the feline study population are summa-
rized in Table 1.The serology test for L. infantum showed that
25.3% (59/233) of the cats had L. infantum seroreactivity, 38
(16.3%) had antibody titers of 1 : 40, 15 (6.4%) had titers of
1 : 80, and 6 (2.6%) had antibody titers of 1 : 160. All blood
samples tested using real-time PCR were negative for the
presence of L. infantum DNA. Standard curve and amplifi-
cation curve of real-time PCR were reported in Figures 1 and
2, respectively.
No statistical association was found between seroreactiv-
ity to L. infantum and age, sex, BCS, municipality of prove-
nance, clinical finding, dermatological findings or FeLV, and
T. gondii serology. In contrast, in terms of CBC, neutrophilia
was statistically associated with seroreactivity to L. infantum
(𝑃 = 0.01) in univariate analysis, but this association was
not confirmed using multivariate logistic regression (𝑃 =
0.57). In terms of serology for the retrovirus, FIV seropositive
status was statistically associated with seroreactivity to L.
infantum (𝑃 = 0.01). This association was confirmed by
multivariate logistic regression: 𝑃 = 0.0098 and OR = 7.34
(95%CI = 1.96 to 27.59). The distribution of the parameters
that were evaluated and compared in L. infantum seropositive
and seronegative cats is shown in Table 1.
4. Discussion
This study is the first epidemiological investigation of feline
Leishmania infection in the metropolitan area of Milan,
which is a nonendemic area for leishmaniasis. We found
seroreactivity to L. infantum by IFAT in 59 of the 233
(25.3%) stray cats that we examined. These results were
surprising, since no autochthonous human or canine cases
of leishmaniasis have ever been reported in this region in
northern Italy. In countries in southern Europe where leish-
maniasis is endemic, serological investigations performed in
feline populations using different techniques have revealed
prevalence rates that range from less than 1% to more than
60% [9–21]. In particular, the seroprevalence in Italy ranges
from 0.9% to 68% [9–11, 13], in Spain from 3.7% to 60%
[14–16], and in Portugal from 0.6% to 2.8% [18–20]. In
Greece, the seroprevalence is 3.9% [17] and in France it is
12.4% [12].These results in L. infantum endemic geographical
regions may reflect differences in the serological techniques
used, in the cut-off values or positive thresholds and in
the populations of cats that were tested. As here, previous
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Table 1: Characteristics of a population of stray cats in northern Italy and a comparison of characteristics in Leishmania infantum seropositive
versus seronegative cats as determined using an indirect immunofluorescence antibody test.
Factor Category Totalpopulation
Sero
positive
Sero
negative Univariate 𝑃-value
Age Young (≤6 months) 106 (45.5%) 24 (40.7%) 82 (47.1%) 0.4788
Adult (>6 months) 127 (54.5%) 35 (59.3%) 92 (52.9%)
Sex Female 153 (65.7%) 38 (64.4%) 115 (66.1%) 0.9387
Male 80 (34.3%) 21 (35.6%) 59 (33.9%)
BCS Scarce (≤3/9) 19 (8.8%) 4 (7.4%) 15 (9.3%) 0.8802
Good (≥4/9) 196 (91.2%) 50 (92.6%) 146 (90.7%)
Colony of origin
Zone 2 11 (4.7%) 2 (3.4%) 9 (5.2%)
0.0825
Zone 4 95 (40.8%) 18 (30.5%) 77 (44.2%)
Zone 5 9 (3.9%) 0 (0.0%) 9 (5.2%)
Zone 6 23 (9.9%) 8 (13.6%) 15 (8.6%)
Zone 7 53 (22.7%) 17 (28.8%) 36 (20.7%)
Zone 8 21 (9.0%) 5 (8.5%) 16 (9.2%)
Zone 9 21 (9.0%) 9 (15.2%) 12 (6.9%)
Clinical examination
Healthy 49 (21.0%) 12 (20.3%) 37 (21.3%) 0.9728
Unhealthy 184 (79.0%) 47 (79.7%) 137 (78.7%)
Stomatitis 92 (39.5%) 17 (28.8%) 75 (43.1%) 0.0740
Ocular discharge 35 (15.0%) 10 (16.9%) 25 (14.4%) 0.7881
Nasal discharge 21 (9.0%) 5 (8.5%) 16 (9.2%) 0.9236
Pale mucous membranes 12 (5.2%) 4 (6.8%) 8 (4.6%) 0.7532
Lymphadenomegaly 117 (50.2%) 30 (50.8%) 87 (50%) 0.9696
Dermatological examination
Absence of lesions 83 (68.6%) 17 (54.8%) 66 (73.3%) 0.0912
Presence of lesions 38 (31.4%) 14 (45.2%) 24 (26.7%)
Crusted dermatitis 22 (18.2%) 7 (22.6%) 15 (16.7%) 0.6410
Scaling 5 (4.1%) 1 (3.2%) 4 (4.4%) 0.8188
Nodular dermatitis 3 (2.5%) 2 (6.5%) 1 (1.1%) 0.3273
Alopecia 18 (14.9%) 8 (25.8%) 10 (11.1%) 0.0910
Ectoparasites 27 (22.3%) 6 (22.2%) 21 (77.8%) 0.8346
Dermatophytosis 9 (7.4%) 1 (3.2%) 8 (8.9%) 0.5225
CBC results
Absence of anemia 29 (22.8%) 5 (16.7%) 24 (24.7%) 0.5015
Presence of anemia 98 (77.2%) 25 (83.3%) 73 (75.3%)
Decreased Ht 97 (76.4%) 25 (83.3%) 72 (74.2%) 0.4352
Decreased Hb 23 (18.1%) 7 (23.3%) 16 (16.5%) 0.5627
Decreased RBC 41 (32.3%) 11 (36.7%) 30 (30.9%) 0.7158
Thrombocytopenia 10 (7.9%) 2 (7.7%) 8 (8.2%) 0.9149
Leukocytosis 5 (3.9%) 2 (6.7%) 3 (3.1%) 0.7319
Leukopenia 15 (11.8%) 3 (10.0%) 12 (12.4%) 0.9776
Neutrophilia 15 (11.8%) 8 (26.7%) 7 (7.2%) 0.01 (0.57)∗
Neutropenia 2 (1.6%) 0 (0.0%) 2 (2.1%) 0.9631
Lymphocytosis 2 (1.6%) 0 (0.0%) 2 (2.1%) 0.9631
Lymphopenia 33 (26.0%) 12 (40.0%) 21 (21.6%) 0.0776
Eosinophilia 12 (9.4%) 4 (13.3%) 8 (8.2%) 0.6346
Eosinopenia 33 (26.0%) 9 (30.0%) 24 (24.7%) 0.7371
FIV status Positive 12 (8.8%) 7 (21.2%) 5 (4.8%) 0.01 (0.0098)
∗
Negative 125 (91.2%) 26 (78.8%) 99 (95.2%) OR = 7.34∗ (95% CI 1.96–27.59)
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Table 1: Continued.
Factor Category Totalpopulation
Sero
positive
Sero
negative Univariate 𝑃-value
FeLV status Positive 5 (3.6%) 0 (0.0%) 5 (4.8%) 0.453
Negative 132 (96.4%) 33 (100.0%) 99 (95.2%)
T. gondii status Positive 26 (32.9%) 9 (36.0%) 17 (31.5%) 0.8886
Negative 53 (67.1%) 16 (64.0%) 37 (68.5)
BCS: body condition score; CBC: complete blood count; Ht: hematocrit, Hb: hemoglobin, RBC: red blood cells, FIV: Feline immunodeficiency virus; FeLV:
Feline Leukemia virus; OR: odds ratio; CI: confidence interval.
𝑃-values in bold are statistically significant (𝑃 < 0.05).
∗Results from multivariate logistic regression analysis.
epidemiological studies have used IFAT to detect antibodies
to Leishmania spp. in cats. An important concern is that there
is no standardized IFAT method for serological evaluation
of antibodies to Leishmania spp. in cats; accordingly, there
is no universally accepted antibody titer cut-off value that
corresponds to active infection. Cut-off titers validated in
dogs are used frequently for cats, but the immune response
could be different in cats than in dogs.
None of the peripheral blood samples we examined using
real-time PCR were positive for parasite DNA. PCR has been
used previously by others, either alone or in combination
with serology, as in our study, to assess the prevalence
of feline Leishmania infection [9, 11, 14, 24, 25]. Blood is
not the best specimen for PCR diagnosis of leishmaniasis.
Specifically, PCR performed on canine blood has lower
sensitivity, specificity, and positive and negative predictive
values compared to PCR performed on canine lymph node
aspirates [26], and this may be true for samples from cats
as well. However, blood sampling is less invasive and is easy
to perform, particularly for epidemiological studies involving
numerous subjects, as in our survey.
Although dogs have been universally regarded as the
domestic reservoir hosts of zoonotic visceral leishmaniasis
caused by L. infantum, some researchers have hypothesized
that cats may also act as a secondary reservoir host of
leishmaniasis rather than simply as an accidental host [9, 14,
15]. Differences in immune response, vector host preference,
or innate resistance in cats to vector-borne diseases could
account for the observed differences in the prevalence of
infection in canine versus feline populations in endemic
areas. Immunosuppressive agents, such as FIV or FeLV, or
disease and stress, can induce immunological dysfunction
and impair the cellular immune response. This allows active
multiplication of the parasite and widespread visceral dis-
semination of the protozoa [27]. In our survey, FIV infection
was statistically associated with seroreactivity to L. infantum
by IFAT, and FIV-positive cats were 7.3 times more likely
to be L. infantum seroreactive than FIV-negative cats (𝑃 =
0.0098). This association has also been found in previous
studies performed in endemic area of Southern Italy [9, 11].
Based on results from a recent survey, continental north-
ern Italy is now focally endemic for leishmaniasis, but no
sand-flies (vector) or autochthonous cases of human and
canine leishmaniasis have been identified in Milan or its
suburbs [28]. Cases of CanL are commonly diagnosed in the
area where we performed our study, but the histories of the
affected dogs always reveal that they have lived or travelled in
areas that are endemic for CanL [29, 30]. A canine epidemio-
logical survey of 313 dogs in a public animal shelter that were
tested for L. infantum by IFAT more than 10 years ago (2002-
2003) in the urban area of Milan found a seroprevalence of
3.4% [31] Although the history of dogs in animal shelters is
often unknown, some of these dogs may have come from
areas that are endemic for L. infantum infection. In contrast,
it is unlikely that all of the Leishmania seropositive cats
found in our study population were infected in endemic
areas. In the present study, the feline seroprevalence for L.
infantum was much higher than the canine seroprevalence
found 10 years previously in a canine population in an
animal shelter in the same area. Notably, this area is still
considered nonendemic for leishmaniasis. We speculate that
the serology results for leishmaniasis in our survey may
be an overestimation due to the possibility of IFAT cross-
reactivity between L. infantum and other pathogens. Cross-
reactivity with other pathogens is possible on some serologic
tests, especially those that use a whole-parasite antigen, as
we did here. There was no significant correlation between
T. gondii positivity and L. infantum positivity in our study.
This may suggest a lack of cross-reactivity with Toxoplasma
parasites. New vector-borne parasites have been found that
affect cats, such as Ehrlichia spp., Rickettsia felis, Anaplasma
phagocytophilum, and Babesia spp. (according to the vector-
borne disease ESCCAP guidelines) [32] that might be able
to cross-react with Leishmania. This has been demonstrated
in dogs in that IFAT cross-reactivity has been reported for
L. infantum and Trypanosoma cruzi, Leishmania braziliensis,
and Ehrlichia canis infection [33].
5. Conclusions
Our results demonstrate high levels of seroreactivity to
L. infantum in cats in an area of northern Italy that has
traditionally been considered to be free of leishmaniasis and
nonendemic for this infection in dogs. Possible IFAT cross-
reactivity and a lack of a validated serological method for
feline specie could explain our unexpectedly high seropreva-
lence. Additional studies that include parasite isolation are
needed to clarify our findings on feline leishmaniasis in this
geographic area.
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Figure 1: Standard curve in logarithmic scale.
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Figure 2: Amplification curve: amplification of the standards (from
106 Leish/mL to 100 Leish/mL). Below the threshold the nonampli-
fied samples (negative).
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